David A Calhoun Selected Research

Thiazides

1/2020	Antihypertensive Medication Adherence and Confirmation of True Refractory Hypertension.
1/2019	Resistant Hypertension Management: Comparison of the 2017 American and 2018 European High Blood Pressure Guidelines.
1/2019	Treatment of Resistant and Refractory Hypertension.
11/2018	Resistant Hypertension: Detection, Evaluation, and Management: A Scientific Statement From the American Heart Association.
1/2018	Refractory Hypertension Is not Attributable to Intravascular Fluid Retention as Determined by Intracardiac Volumes.
11/2014	Stroke outcomes among participants randomized to chlorthalidone, amlodipine or lisinopril in ALLHAT.
10/2014	Detection, evaluation, and treatment of severe and resistant hypertension: proceedings from an American Society of Hypertension Interactive forum held in Bethesda, MD, U.S.A., October 10th 2013.
1/2013	Hyperaldosteronism as a common cause of resistant hypertension.
9/2011	Aldosterone blockers (mineralocorticoid receptor antagonism) and potassium-sparing diuretics.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

David A Calhoun Research Topics

Disease

117	Hypertension (High Blood Pressure) 12/2023 - 12/2002
27	Hyperaldosteronism (Conn Syndrome) 01/2020 - 12/2002
11	Obstructive Sleep Apnea 01/2019 - 03/2004
10	Chronic Renal Insufficiency 01/2021 - 01/2007
10	Obesity 01/2018 - 03/2004
9	Stroke (Strokes) 07/2015 - 04/2011
8	Heart Failure 01/2022 - 06/2005
8	Cardiovascular Diseases (Cardiovascular Disease) 01/2020 - 08/2002
8	Myocardial Infarction 04/2017 - 06/2003
7	Sleep Apnea Syndromes (Sleep Apnea) 01/2018 - 01/2004
6	Hyperkalemia 05/2012 - 05/2006
4	Left Ventricular Hypertrophy (Ventricular Hypertrophy, Left) 01/2019 - 05/2010
4	Essential Hypertension 01/2013 - 09/2011
3	Inflammation (Inflammations) 01/2016 - 02/2009
3	Isolated Systolic Hypertension 03/2014 - 11/2009
3	Hypokalemia 05/2012 - 06/2005
3	Weight Loss (Weight Reduction) 11/2009 - 03/2006
3	Adenoma (Adenomas) 03/2009 - 11/2005
2	Hypoxia (Hypoxemia) 01/2019 - 02/2012
2	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2018 - 02/2009
2	Coronary Disease (Coronary Heart Disease) 11/2014 - 10/2013
2	Type 2 Diabetes Mellitus (MODY) 10/2014 - 10/2014
1	Pre-Eclampsia (Preeclampsia) 01/2021
1	Gout 01/2021
1	Hypertrophy 01/2019
1	Abdominal Obesity 10/2016
1	Hyperuricemia 01/2016
1	Chronic Kidney Failure (Chronic Renal Failure) 11/2014
1	Peripheral Arterial Disease 11/2014
1	White Coat Hypertension 10/2014
1	Diabetes Mellitus 10/2013

Drug/Important Bio-Agent (IBA)

70	Antihypertensive Agents (Antihypertensives)IBA 01/2023 - 08/2002
50	AldosteroneIBA 01/2021 - 12/2002
30	DiureticsIBA 01/2020 - 11/2003
27	Mineralocorticoid Receptor AntagonistsIBA 01/2021 - 03/2004
23	ReninIBA 01/2020 - 12/2002
20	Spironolactone (Aldactone)FDA LinkGeneric 12/2023 - 12/2002
18	SodiumIBA 01/2022 - 12/2002
12	SaltsIBA 01/2021 - 12/2002
11	Chlorthalidone (Chlortalidone)FDA LinkGeneric 01/2020 - 01/2007
10	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 01/2019 - 11/2003
9	ThiazidesIBA 01/2020 - 09/2011
9	Hydrochlorothiazide (Esidrix)FDA LinkGeneric 08/2013 - 06/2005
8	Angiotensin Receptor AntagonistsIBA 01/2019 - 11/2003
7	Sodium Chloride Symporter Inhibitors (Diuretics, Thiazide)IBA 01/2023 - 11/2008
7	Dietary SodiumIBA 01/2019 - 02/2008
6	PotassiumIBA 09/2014 - 11/2007
5	Calcium Channel Blockers (Blockers, Calcium Channel)IBA 01/2019 - 10/2013
5	Eplerenone (Inspra)FDA LinkGeneric 11/2018 - 06/2005
5	LipidsIBA 04/2017 - 10/2005
5	Amlodipine (Norvasc)FDA LinkGeneric 04/2017 - 07/2009
4	Valsartan (Vals)FDA Link 08/2013 - 06/2008
3	AngiotensinsIBA 01/2019 - 06/2005
3	Drug CombinationsIBA 01/2019 - 06/2008
3	Mineralocorticoid Receptors (Mineralocorticoid Receptor)IBA 01/2018 - 05/2010
3	Lisinopril (Prinivil)FDA LinkGeneric 04/2017 - 05/2012
3	Amiloride (Midamor)FDA LinkGeneric 01/2014 - 05/2006
3	CreatinineIBA 09/2013 - 06/2003
2	Mitochondrial DNA (mtDNA)IBA 01/2022 - 11/2017
2	Xanthine OxidaseIBA 01/2022 - 01/2019
2	Uric Acid (Urate)IBA 01/2021 - 01/2016
2	Hydrocortisone (Cortisol)FDA LinkGeneric 05/2017 - 06/2008
2	Brain Natriuretic Peptide (Natrecor)FDA Link 09/2016 - 05/2010
2	Triamterene (Dyrenium)FDA LinkGeneric 01/2016 - 09/2011
2	Sodium Potassium Chloride Symporter Inhibitors (Loop Diuretics)IBA 10/2014 - 09/2011
2	Valsartan Drug Combination Amlodipine FDA Link 08/2013 - 11/2009
2	Peptidyl-Dipeptidase A (Angiotensin Converting Enzyme)IBA 06/2005 - 11/2003
1	GlycogenIBA 01/2022
1	CatecholaminesIBA 01/2021
1	Biomarkers (Surrogate Marker)IBA 01/2021
1	Reserpine (Serpasil)FDA Link 01/2020
1	Oxyhemoglobins (Oxyhemoglobin)IBA 01/2019
1	Indapamide FDA LinkGeneric 11/2018
1	Cortisone FDA Link 05/2017
1	Oxidoreductases (Dehydrogenase)IBA 05/2017
1	Norepinephrine (Noradrenaline)FDA LinkGeneric 09/2016
1	NormetanephrineIBA 07/2015
1	SympatholyticsIBA 07/2015
1	Dipyridamole (Persantine)FDA LinkGeneric 02/2015
1	Hypoglycemic Agents (Hypoglycemics)IBA 10/2014
1	salicylhydroxamic acid (SHAM)IBA 10/2014
1	dulaglutideIBA 10/2014
1	Glucagon-Like Peptide-1 ReceptorIBA 10/2014
1	Glucagon-Like Peptide-1 Receptor AgonistsIBA 10/2014
1	N 30IBA 03/2014
1	Sodium Channels (Sodium Channel)IBA 01/2014
1	ORALIT (ORS)IBA 10/2013
1	erucylphosphocholineIBA 09/2013
1	AlbuminsIBA 09/2013
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 09/2013
1	CytokinesIBA 09/2013
1	IsoprostanesIBA 02/2012
1	hydroxide ionIBA 01/2012
1	C-Reactive ProteinIBA 01/2012

Therapy/Procedure

27	Therapeutics 01/2021 - 08/2002
4	Denervation 01/2017 - 01/2012
3	Ambulatory Care (Outpatient Care) 01/2020 - 04/2017
2	Drug Therapy (Chemotherapy) 10/2014 - 10/2013
2	Dietary Approaches To Stop Hypertension 09/2014 - 02/2013
1	Coronary Artery Bypass (Coronary Artery Bypass Surgery) 01/2018